Macular Disease Foundation Australia (MDFA) has appointed Professor Sanchia Aranda AM as its new Chair, following Graeme Head AO stepping down after four years in the role.
Prof Aranda, who joined the MDFA Board in 2025, brings extensive expertise across health, education, research, disability and the for-purpose sector. She has led organisational transformation, strengthened governance, championed consumer involvement in cancer research, and is highly experienced in leading public education campaigns.
Together, we look ahead to new opportunities to strengthen this community, deepen our impact, broaden our research agenda, and ensure that every Australian has the best chance of preserving their sight
Currently Chair of Scope Australia and the Victorian Comprehensive Cancer Centre Alliance, Prof Aranda began her career in nursing and was the first nurse to lead Cancer Council Australia as CEO.
With a strong family history of age-related macular degeneration, that affected both parents she is passionate about contributing to changing public understanding of macular disease.
“Stepping into the role of Chair is a privilege,” she said. “I extend my sincere thanks to Graeme Head AO for his outstanding leadership and steady stewardship of Macular Disease Foundation Australia.
“As we approach the Foundation’s 25th anniversary, we honour a legacy built by a community supporting one another, empowering thousands of Australians living with macular disease. Together, we look ahead to new opportunities to strengthen this community, deepen our impact, broaden our research agenda, and ensure that every Australian has the best chance of preserving their sight.”
Mr Head’s departure coincides with his appointment as the new CEO of the National Disability Insurance Agency (NDIA) in November this year.
“Macular Disease Foundation and fellow Board members sincerely thank Graeme for his commitment and guidance, which have strengthened our organisation and its support for the macular disease community,” said MDFA CEO, Dr Kathy Chapman. “Professor Aranda’s leadership will be pivotal as we advance research, advocacy and improve outcomes for Australians living with macular disease.”
Professor Aranda’s appointment as Chair is effective immediately.
